期刊文献+

基于计划行为理论的家长对女中学生接种人乳头瘤病毒疫苗意愿及影响因素研究 被引量:5

Parents’ willingness on human papillomavirus vaccine vaccination for middle school girls based on theory of planned behavior and study on its influencing factors
下载PDF
导出
摘要 目的以计划行为理论为框架,了解浙江省家长对女中学生接种人乳头瘤病毒疫苗接种意愿及影响因素。方法采取自行设计的《浙江省家长对女中学生接种人乳头瘤病毒疫苗接受度调查表》对283名女中学生(12~<18岁)家长进行调查,采用单因素分析、Pearson相关分析及多元Logistic回归分析了解影响接种疫苗意愿的因素。结果 283名家长对女中学生接种人乳头瘤病毒疫苗行为意愿得分(4.47±1.23)分,接种人乳头瘤病毒疫苗态度、性行为影响态度、主观规范、知觉行为控制、家族中有人曾患妇科肿瘤或妇科感染是影响家长对女中学生接种人乳头瘤病毒疫苗意愿的因素。结论家长对女中学生接种人乳头瘤病毒疫苗意愿较一般,受多种因素的影响。 Abstrct: Objective To study parents’ willingness on human papillomavirus vaccine(HPV) vaccination for middle school girls in Zhejiang Province based on theory of planned behavior and its influencing factors. Method Investigate 284 parents of middle school girls(12~<18 years old) by self-designed questionnaire on acceptance level of parents on HPV vaccination for middle school girls in Zhejiang Province. Analyze and understand the influencing factors of acceptance level on HPV vaccination by single factor analysis, Pearson correlation analysis and multivariate Logistic regression. Result Score on planned behavior of 283 parents on HPV vaccination for middle school girls is(4.47±1.23). Attitude on HPV vaccination, attitude on sexual behavior, subjective norms, perceived behavioral control and gynecological tumor or gynecological infections history in family are influencing factors of parents’ willingness on HPV vaccination for middle school girls. Conclusion Parents’ acceptance on HPV vaccination for middle school girls at their own expenses is in median level, which is influenced by many factors.
作者 李晓 屠乐微 裘如兰 梁廷 Li Xiao;Tu Lewei;Qiu Rulan;Liang Ting(Nursing School of Zhejiang Chinese Medical University,Hangzhou Zhejiang 310053,China)
出处 《护理与康复》 2020年第5期19-23,27,共6页 Journal of Nursing and Rehabilitation
关键词 人乳头瘤病毒 疫苗 中学生 家长 计划行为理论 human papillomavirus vaccine middle school student parent theory of planned behavior
  • 相关文献

参考文献8

二级参考文献87

  • 1庞建宏,朱红梅,刘珊玲.HPV疫苗临床应用的评价[J].实用妇产科杂志,2010,26(3):177-184. 被引量:4
  • 2王丙刚,曲波,郭海强,张蕾,金鑫,李刚,孙高.传染病预测的数学模型研究[J].中国卫生统计,2007,24(5):536-540. 被引量:105
  • 3Jemal A, Bray F, Center MM, et al. Global Cancer Statistic [ J ]. CA Cancer J Clin,2011,61 ( 2 ) :69-90. 被引量:1
  • 4Siegel R,Nais hadham D,Jemal A. Cancer statistics[ J]. CA Cancer J Clin,2013,63( 1 ) :11-59. 被引量:1
  • 5Jin XW, Sikon A, Yen Lieberman B. Cervical cancer screening: Less testing,smarter testing [ J ]. Cleve Clin J Med, 2011,78 ( 11 ) : 737- 747. 被引量:1
  • 6Satterwhite CL, Torrone E, Meites E, et al. Sexually transmitted infec- tions among US women and men:prevalence and incidence estimates, 2008[ J]. Sex Transm Dis,2013,40(3) :187-193. 被引量:1
  • 7Castellsague X, Munoz N, Pitisuttithum P, et al. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV ( types 6, 11,16, 18 )recombinant vaccine in adult women 24 -45 years of age[ J]. Br J Cancer,2011,105 ( 1 ) :28-37. 被引量:1
  • 8Lehtinen M, Paavonen J, Wheeler CM, et al. Overall efficacy of HPV- 16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical in- traepithelial neoplasia :4-year end-of-study analysis of the randomised, double-blind PATRICIA trial[ J]. Lancet Oncol,2012,13( 1 ) :89-99. 被引量:1
  • 9Wheeler CM, CasteUsague X, Garland SM, et al. Cross-protective effi- cacy of HPV-16./18 AS04-adjuvanted vaccine against cervical infec- tion and precancer caused by non-vaccine oncogenic HPV types:4- year end-of-study analysis of the randomised, double-blind PATRI- CIA trial[ J]. Lancet Oncol,2012,13 ( 1 ) : 100-110. 被引量:1
  • 10Dobson SR, McNeil S, Dionne M, et al. Immunogenicity of 2 doses of HPV vaccine in younger adolescents vs 3 doses in young women: a randomized clinical trial [ J ]. JAMA, 2013,309 ( 17 ) : 1793-1802. 被引量:1

共引文献125

同被引文献55

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部